Cellular Localization of Estrogen Binding Sites in Human Breast Cancer
- 1 April 1982
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 77 (4) , 391-395
- https://doi.org/10.1093/ajcp/77.4.391
Abstract
Biopsy specimens from 52 consecutive cases of primary human breast cancer were collected over a period of seven months and included in a study for histochemical localization of estrogen binding sites (EBS), using a fluorescein labelled Estradiol conjugate. Cryostat frozen sections from each tumor were examined to determine the localization of the tracer and to evaluate the percentage of positive cells in a given tumor. Results are correlated with the values of the biochemical assay for the estrogen receptor (ER) protein done on the same tumor. The localization of EBS by a tracer is a simple technique that can be done and interpreted in any surgical pathology laboratory. It was concluded that this method could be a valuable supplementary technique to the biochemical assay; allowing more accurate selection of patients and prediction of their response to endocrine therapy. Clinical follow-ups are extremely necessary to evaluate the suitability and the accuracy of the technique in choosing breast cancer patients for endocrine manipulation.This publication has 4 references indexed in Scilit:
- Cellular Estrogen and Progesterone Receptors in Mammary CarcinomaAmerican Journal of Clinical Pathology, 1980
- Relationship between oestrogen-receptor content and histological grade in human primary breast tumoursBritish Journal of Cancer, 1978
- Cytochemical Study of Estrogen Receptor in Human Mammary CancerAmerican Journal of Clinical Pathology, 1978
- Immunofluorescent detection of estrogen receptors in breast cancer.Comparison with dextran-coated charcoal and sucrose gradient assaysCancer, 1978